Objective To investigate the impact of splenectomy on the prognosis and immune function of patients with end stage carcinoma of the esophagogastric.
Methods The clinical data of 61 patients with end stage carcinoma of the esophagogastric junction who were admitted to the First Affiliated Hospital of Fujian Medical University from January 2007 to December 2010 were retrospectively analyzed. All the patients were divided into splenectomy group (22 patients) and spleen preservation group (39 patients). The immune function before operation, on the 10th day and the 6th month after operation was detected. The intra and postoperative conditions of the patients of the 2 groups were compared. All data were analyzed using the independent sample t test or chi square test.
Results The levels of IgA, IgG, IgM, CD3 and CD4 in the splenectomy group at the 10th day after operation were significantly higher than those before operation ( t=2.55, 3.33, 3.40, 2.92, 2.10, P <0.05). The levels of IgA, IgG, IgM, CD3, CD4, the ratio of CD4/CD8 of the spleen preservation group at the 10th day after operation were significantly higher than those before operation ( t=3.35, 5.29, 3.33, 2.60, 3.53, 3.12, P <0.05). The levels of IgA, IgG, IgM, CD3, CD4 and the ratio of CD4/CD8 in the splenectomy group at postoperative month 6 were significantly lower than those at postoperative day 10 ( t=2.75, 4.40, 3.06, 2.51, 2.24, 2.29, P <0.05). The levels of IgA, IgG, IgM, CD4, CD8 and the ratio of CD4/CD8 of the spleen preservation group were significantly higher than those of the splenectomy group, while the level of CD8 in the spleen preservation group was significantly lower than that in the splenectomy group ( t=1.70, 2.10, 2.70, 2.16, 2.13, 2.83, P <0.05). The operation time of the splenectomy group was (152±26)minutes, which 〖HJ*8〗was significantly longer than (130±24)minutes of the spleen preservation group ( t=3.42, P <0.05). There were no significant differences in the operative blood loss, incidence of postoperative infection, median survival time, 1 year survival rate between the 2 groups ( t=1.38, χ 2 =0.78, 1.22, 2.51, P >0.05).
Conclusion Palliative gastrectomy could reverse the immune function of spleen by decreasing tumor burden for patients with end stage carcinoma of the esophagogastric junction who can not be treated by radical resection. Spleen preservation may have positive significance for the immune function and prognosis of patients with end stage carcinoma of the esophagogastric junction.
DownLoad: